This brief describes how workers and consumers have been impacted by the private equity takeover of New York State’s Medicaid-funded home health program known as Consumer Directed Personal Assistance Program (CDPAP), and why it matters for public health.
March 12, 2026
This brief describes how workers and consumers have been impacted by the private equity takeover of New York State’s Medicaid-funded home health program known as Consumer Directed Personal Assistance Program (CDPAP), and why it matters for public health.
.jpg)
This brief describes how workers and consumers have been impacted by the private equity takeover of New York State’s Medicaid-funded home health program known as Consumer Directed Personal Assistance Program (CDPAP), and why it matters for public health.
.jpg)
In April of 2025, private equity-backed firm Public Partnerships, LLC (PPL) became the sole Statewide Fiscal Intermediary for New York State’s Medicaid-funded home health program known as the Consumer Directed Personal Assistance Program (CDPAP). Between April and December of 2025, Caring Majority Rising conducted nine surveys and published nine fact sheets capturing how the transition affected many CDPAP Personal Assistants (PAs), consumers, and designated representatives. Each survey received between 200 and 500 responses.
Hundreds of respondents self-report negative experiences with pay, job security, health insurance, care, and accessibility, according to survey data. This brief describes these findings as reported on the fact sheets and draws from a body of public health research to explain why each issue surfaced in the survey data is a matter of public health concern.
Hundreds of PAs and consumers report concerns about PPL takeover. Based on our research, these concerns have public health and health equity impacts.
The main concerns respondents raised in the surveys are as follows:
Why these findings matter for health:
Publicly accessible programs like CDPAP are essential for health equity. To fulfill the program’s potential, lawmakers must ensure that public dollars are invested in public health.